RU2015147247A3 - - Google Patents

Download PDF

Info

Publication number
RU2015147247A3
RU2015147247A3 RU2015147247A RU2015147247A RU2015147247A3 RU 2015147247 A3 RU2015147247 A3 RU 2015147247A3 RU 2015147247 A RU2015147247 A RU 2015147247A RU 2015147247 A RU2015147247 A RU 2015147247A RU 2015147247 A3 RU2015147247 A3 RU 2015147247A3
Authority
RU
Russia
Application number
RU2015147247A
Other languages
Russian (ru)
Other versions
RU2015147247A (ru
RU2660901C2 (ru
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2014/079098 external-priority patent/WO2014194809A1/zh
Publication of RU2015147247A publication Critical patent/RU2015147247A/ru
Publication of RU2015147247A3 publication Critical patent/RU2015147247A3/ru
Application granted granted Critical
Publication of RU2660901C2 publication Critical patent/RU2660901C2/ru

Links

RU2015147247A 2013-06-05 2014-06-03 Новые соединения, обладающие тройной активностью, тромболизисной, антитромботической и захвата радикалов, и их синтез, наноструктуры и применение RU2660901C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201310225330?6 2013-06-05
CN201310225330 2013-06-05
CN201310225330.6 2013-06-05
PCT/CN2014/079098 WO2014194809A1 (zh) 2013-06-05 2014-06-03 具有溶栓、抗栓和自由基清除三重活性的新型化合物、其合成、纳米结构和应用

Publications (3)

Publication Number Publication Date
RU2015147247A RU2015147247A (ru) 2017-05-05
RU2015147247A3 true RU2015147247A3 (cg-RX-API-DMAC10.html) 2018-01-18
RU2660901C2 RU2660901C2 (ru) 2018-07-11

Family

ID=52007559

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015147247A RU2660901C2 (ru) 2013-06-05 2014-06-03 Новые соединения, обладающие тройной активностью, тромболизисной, антитромботической и захвата радикалов, и их синтез, наноструктуры и применение

Country Status (25)

Country Link
US (5) US9890193B2 (cg-RX-API-DMAC10.html)
EP (1) EP3006454B1 (cg-RX-API-DMAC10.html)
JP (1) JP6510500B2 (cg-RX-API-DMAC10.html)
KR (1) KR102204781B1 (cg-RX-API-DMAC10.html)
CN (1) CN104231046B (cg-RX-API-DMAC10.html)
AU (1) AU2014277416B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015027164B1 (cg-RX-API-DMAC10.html)
CA (1) CA2914004C (cg-RX-API-DMAC10.html)
CY (1) CY1123976T1 (cg-RX-API-DMAC10.html)
DK (1) DK3006454T3 (cg-RX-API-DMAC10.html)
ES (1) ES2847934T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20210566T1 (cg-RX-API-DMAC10.html)
HU (1) HUE053351T2 (cg-RX-API-DMAC10.html)
LT (1) LT3006454T (cg-RX-API-DMAC10.html)
MX (1) MX362902B (cg-RX-API-DMAC10.html)
PH (1) PH12015502684B1 (cg-RX-API-DMAC10.html)
PL (1) PL3006454T3 (cg-RX-API-DMAC10.html)
PT (1) PT3006454T (cg-RX-API-DMAC10.html)
RS (1) RS61606B1 (cg-RX-API-DMAC10.html)
RU (1) RU2660901C2 (cg-RX-API-DMAC10.html)
SI (1) SI3006454T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202100108T1 (cg-RX-API-DMAC10.html)
TW (1) TWI633889B (cg-RX-API-DMAC10.html)
WO (1) WO2014194809A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201507237B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106608902A (zh) * 2015-10-22 2017-05-03 彭莉 二羟基二甲基四氢异喹啉-3-甲酰-Lys(Lys),其合成,活性及应用
CN106608905B (zh) * 2015-10-22 2020-10-16 彭莉 四氢异喹啉-3-甲酰-k(grpak)rgdv,其合成,活性及应用
JP6663774B2 (ja) 2016-03-30 2020-03-13 東京エレクトロン株式会社 基板搬送方法及び基板処理システム
LT4034115T (lt) * 2019-09-25 2025-04-10 Lumosa Therapeutics Co., Ltd. Farmacinė kompozicija, apimanti trombolizinio peptido ir tetrahidroizochinolino konjugatą
KR20230041966A (ko) * 2020-05-15 2023-03-27 신헬릭스 펩티드 스캐폴드, 이를 제조하기 위한 방법, 및 가용성 지지체로서의 이의 용도
CA3212069A1 (en) 2021-03-22 2022-09-29 Jung-Chin Lin Dc009 for treating acute ischemic stroke
CN115403653B (zh) * 2022-05-19 2024-08-06 首都医科大学 D(+)-β-(3,4-二羟基苯基)-乳酰-Pro-Ala-Lys,其合成及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5222632B2 (cg-RX-API-DMAC10.html) * 1972-08-22 1977-06-18
JP2004523530A (ja) 2001-01-23 2004-08-05 イーライ・リリー・アンド・カンパニー メラノコルチン受容体アゴニストとしてのピペラジンおよびピペリジン誘導体
EP1469851B1 (en) 2002-01-23 2006-10-11 Eli Lilly And Company Melanocortin receptor agonists
JP2006525942A (ja) * 2002-12-23 2006-11-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ トロンビン受容体アンタゴニストとしての新規なヘテロアリールペプチド模倣物
CN101190941B (zh) * 2006-11-30 2010-12-01 首都医科大学 具有溶血栓活性的多肽、其制备方法及应用
CN101190895B (zh) 2006-11-30 2010-05-26 首都医科大学 N-[(3s)-1,2,3,4-四氢异喹啉-3-甲酰基]氨基酸、其制备方法及应用
CN101200493B (zh) 2006-12-11 2011-11-09 首都医科大学 (3s)-n-(l-氨基酰)-1,2,3,4-四氢异喹啉-3-羧酸、其制备方法及应用
CN102241740B (zh) * 2008-01-30 2014-02-19 首都医科大学 具有溶血栓活性的化合物、其制备方法、其应用
CN101497651B (zh) 2008-01-30 2012-06-27 首都医科大学 具有溶血栓活性的化合物、其制备方法、其应用
CN101899084B (zh) 2009-05-26 2012-09-05 首都医科大学 (3s)-1,2,3,4-四氢异喹啉-3-羧酸三肽缀合物及其制备方法和应用
CN102120727B (zh) 2010-01-07 2013-08-28 首都医科大学 N-[(3s)-n-氨基酰-1,2,3,4-四氢异喹啉-3-甲酰基]氨基酸及其合成方法和应用
CN102127097A (zh) 2010-01-15 2011-07-20 首都医科大学 N-(3s-1,2,3,4-四氢异喹啉-3-甲酰基)氨基酸铜络合物及其制备方法和应用
CN102477068B (zh) 2010-11-30 2013-07-24 首都医科大学 用于制备溶血栓药物的氨基酸衍生物及其制备方法和应用
LT2766346T (lt) * 2011-10-14 2017-06-12 Bristol-Myers Squibb Company Pakeistieji tetrahidroizochinolino junginiai, kaip faktoriaus xia inhibitoriai
CN103145797B (zh) 2011-12-07 2015-05-20 首都医科大学 [(3s)-1,2,3,4-四氢异喹啉-3-甲酰基]-Lys修饰的RGD四肽,其合成和在医学中的应用
CN103450338B (zh) 2012-05-29 2016-08-24 首都医科大学 杂环羧酸修饰的胸腺五肽,其制备,抗肿瘤作用和应用
CN103450330B (zh) * 2012-06-01 2016-05-25 首都医科大学 二羟基四氢异喹啉-3-甲酰氨基酸、其合成、抗血栓作用和应用
TWI568747B (zh) * 2012-09-05 2017-02-01 上海晟順生物科技有限公司 同時具溶血栓、清除自由基和血栓靶向功能的新穎化合物及其製備方法和用途
CN102887941A (zh) * 2012-09-05 2013-01-23 永光制药有限公司 Pak/咪唑啉/rgd三元缀合物及其制备方法和用途

Similar Documents

Publication Publication Date Title
BR112021000792B8 (cg-RX-API-DMAC10.html)
AT524874A5 (cg-RX-API-DMAC10.html)
AT524834A2 (cg-RX-API-DMAC10.html)
AU2018438767B1 (cg-RX-API-DMAC10.html)
AT521543A3 (cg-RX-API-DMAC10.html)
AT524266A2 (cg-RX-API-DMAC10.html)
BR102019026286B1 (pt) Método e aparelho para o avanço de produtos a serem moldados
BR102019025884B1 (pt) Sistema de segurança aprimorado para máquinas de operação de autopropulsão
BR102019023514B1 (pt) Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna
BR112020016338B1 (pt) Dispositivo para tratamento de tecido corporal
BR112021001434B1 (pt) Aço com alto teor de manganês e método de produção do mesmo
BR112021001374B1 (pt) Composição farmacêutica para o tratamento da hipertensão e seu uso
BR112021001128B1 (pt) Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit
BR112021001186B1 (pt) Aparelho para o tratamento de celulite para tratar expressões de celulite na pele de um paciente associadas a um local de tratamento de septos
BR112021000922B1 (pt) Tela de filtro, e, método para purificar água de alimentação
BR112020026077B1 (pt) Recipiente com estrutura encaixável
BR112020026721B1 (pt) Aparelho de moldagem para modar uma folha de um material contendo alcaloides
BR102019012845B1 (pt) Montagens de guia de entrada de piso de compartimento de carga retráteis para carregamentos paletizados em aeronaves de carga e aeronave e carga
BR112020023832B1 (pt) Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral
BR112020024987B1 (pt) Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico
BR112020022482B1 (pt) Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico
BR112020022658B1 (pt) Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido
BR112020022516B1 (pt) Processo para degomagem enzimática de óleo
BR112020021042B1 (pt) Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas
BR112020020812B1 (pt) Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado